Does Wearing-Off of Efficacy Occur in Galcanezumab-Treated Patients at the End of the Monthly Treatment Cycle: A Post Hoc Analysis of Four Phase 3 Randomized Trials

被引：0
|
作者：
Ailani, Jessica [1 ]
Kuruppu, Dulanji [2 ]
Rettiganti, Mallikarjuna [2 ]
Oakes, Tina [2 ]
Wietecha, Linda [2 ]
Port, Martha [2 ]
Blumenfeld, Andrew [3 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Neurol Ctr Southern Calif, La Jolla, CA USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1922
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A Post Hoc Analysis of Immunoglobulin Levels in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod in Phase 3 Trials
    Harris, S.
    Southworth, H.
    Sheffield, J. K.
    Maddux, R.
    Cohen, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 93 - 94
  • [22] Efficacy of Sarecycline for Facial Acne Vulgaris in Patients With Skin of Color: Post Hoc Analysis of Phase 3 Trials
    Keri, Jonette
    Harper, Julie
    Baldwin, Hilary
    Graber, Emmy
    Salem, Raidah
    Tomondy, Paul
    Hernandez, Francisco
    Alexis, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB43 - AB43
  • [23] Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States
    Varnado, Oralee J.
    Ye, Wenyu
    Mi, Xiaojuan
    Burge, Russel
    Hall, Jerry
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 149 - 157
  • [24] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
    Norton, Hillary
    Sliwinska-Stanczyk, Paula
    Hala, Tomas
    Elzorkany, Bassel
    Stockert, Lori
    Shi, Harry
    Wang, Cunshan
    Paulissen, Jerome
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803
  • [25] Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
    Gustavo Citera
    Rakesh Jain
    Fedra Irazoque
    Hugo Madariaga
    David Gruben
    Lisy Wang
    Lori Stockert
    Karina Santana
    Abbas Ebrahim
    Dario Ponce de Leon
    Rheumatology and Therapy, 2024, 11 : 35 - 50
  • [26] Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
    Citera, Gustavo
    Jain, Rakesh
    Irazoque, Fedra
    Madariaga, Hugo
    Gruben, David
    Wang, Lisy
    Stockert, Lori
    Santana, Karina
    Ebrahim, Abbas
    Ponce de Leon, Dario
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 35 - 50
  • [27] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    Tesser, John
    Gul, Ahmet
    Olech, Ewa
    Oelke, Kurt
    Lukic, Tatjana
    Kwok, Kenneth
    Ebrahim, Abbas
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [28] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    John Tesser
    Ahmet Gül
    Ewa Olech
    Kurt Oelke
    Tatjana Lukic
    Kenneth Kwok
    Abbas Ebrahim
    Arthritis Research & Therapy, 25
  • [29] High Cleansing Efficacy of Ner1006 Also in the Elderly: Post Hoc Subgroup Analysis of Randomized Phase 3 Trials
    Jover, Rodrigo
    Shing, Richard Ng Kwet
    Uebel, Peter
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB195 - AB195
  • [30] Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
    Stauffer, Virginia L.
    Turner, Ira
    Kemmer, Phebe
    Kielbasa, William
    Day, Kathleen
    Port, Martha
    Quinlan, Tonya
    Camporeale, Angelo
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
12345